Agency
County of Union
County of Union was paid $6.81M by Medicaid between Jan 2018 and Dec 2024, across 124 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 57% of everything it billed.
33Billing provider infoCOUNTY OF UNION
MONROE, NC 28110
MONROE, NC 28110
33aNPI1386787422assigned 02/15/2007
33bProvider typePublic Health or Welfare Agency
28Total paid$6.81M
24GClaims926,102
24DCodes billed124
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Public Health or Welfare Agency providers in North Carolina
Rank by total paid#3 of 25
Median peer was paid$1.15M
This provider vs. median5.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,804 | $429K | |
| 2019 | 16,619 | $406K | |
| 2020 | 15,680 | $355K | |
| 2021 | 113,461 | $999K | |
| 2022 | 214,992 | $1.42M | |
| 2023 | 264,288 | $1.57M | |
| 2024incomplete | 283,258 | $1.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 57% | 769,730 | 694,714 | $3.89M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.1% | 8,154 | 5,980 | $553K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 3,499 | 2,777 | $359K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.3% | 3,224 | 2,778 | $294K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.1% | 2,377 | 1,979 | $209K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.0% | 2,788 | 2,236 | $206K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.9% | 3,140 | 2,217 | $196K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.0% | 13,522 | 11,039 | $136K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.8% | 6,962 | 5,568 | $125K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.2% | 2,967 | 2,158 | $83K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.0% | 1,470 | 1,124 | $70K |
| 0001A | <1% | 1,086 | 906 | $52K |
112 more codes
| 0002A | <1% | 998 | $50K | |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 1,322 | $49K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 1,471 | $32K |
| D0120 | Dental checkup, returning patient | <1% | 1,046 | $30K |
| 96127 | <1% | 6,623 | $27K | |
| 90651 | <1% | 1,458 | $25K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 370 | $22K |
| 92587 | <1% | 7,438 | $20K | |
| D1120 | Dental cleaning, child | <1% | 618 | $19K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 1,032 | $19K |
| 99502 | <1% | 322 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,599 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 637 | $17K |
| 90474 | <1% | 1,841 | $17K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,476 | $14K |
| D1110 | Prophylaxis - adult | <1% | 349 | $14K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 521 | $13K |
| 86480 | <1% | 978 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,428 | $13K |
| T1002 | Rn services, up to 15 minutes | <1% | 682 | $13K |
| 0071A | <1% | 360 | $12K | |
| 0072A | <1% | 324 | $12K | |
| 90734 | <1% | 800 | $12K | |
| 90686 | <1% | 6,428 | $12K | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | <1% | 241 | $12K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 190 | $10K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 86 | $9K |
| 96160 | <1% | 3,533 | $8K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 670 | $8K |
| 90715 | <1% | 1,116 | $8K | |
| 90621 | <1% | 262 | $7K | |
| 81003 | <1% | 2,959 | $7K | |
| 90698 | <1% | 1,140 | $6K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,164 | $6K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 171 | $5K |
| 90716 | <1% | 1,310 | $5K | |
| 0053A | <1% | 60 | $3K | |
| D0330 | Panoramic radiographic image | <1% | 76 | $3K |
| 90480 | <1% | 209 | $3K | |
| 0003A | <1% | 83 | $3K | |
| 90707 | <1% | 1,079 | $3K | |
| 99245 | <1% | 12 | $2K | |
| 96161 | <1% | 1,948 | $2K | |
| 99492 | <1% | 12 | $2K | |
| 99493 | <1% | 15 | $2K | |
| 0054A | <1% | 34 | $2K | |
| 85018 | <1% | 1,988 | $2K | |
| 83655 | <1% | 1,458 | $1K | |
| 0031A | <1% | 22 | $1K | |
| 0124A | <1% | 62 | $1K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 17 | $1K |
| D0274 | Bitewings - four radiographic images | <1% | 48 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 183 | $1K |
| 82950 | <1% | 184 | $1K | |
| 81025 | <1% | 195 | $1K | |
| 0012A | <1% | 17 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,104 | $945.22 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,882 | $940.98 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,092 | $913.32 |
| 90670 | <1% | 2,365 | $825.66 | |
| D0272 | Bitewings - two radiographic images | <1% | 43 | $793.65 |
| D0220 | Intraoral - periapical first radiographic image | <1% | 44 | $721.60 |
| 90672 | <1% | 225 | $595.68 | |
| 87210 | <1% | 134 | $480.15 | |
| 82120 | <1% | 131 | $430.20 | |
| 90473 | <1% | 123 | $407.40 | |
| 97803 | <1% | 14 | $405.80 | |
| 80061 | Lipid panel | <1% | 994 | $398.83 |
| 0011A | <1% | 24 | $384.92 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 39 | $359.17 |
| 90619 | <1% | 879 | $320.07 | |
| 90656 | <1% | 122 | $304.00 | |
| 90677 | <1% | 307 | $268.63 | |
| 80053 | Comprehensive metabolic panel | <1% | 749 | $236.56 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,240 | $179.37 |
| 90633 | <1% | 1,062 | $161.56 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,083 | $158.86 |
| 86592 | <1% | 1,617 | $118.31 | |
| 82947 | <1% | 33 | $102.67 | |
| 90680 | <1% | 1,888 | $92.44 | |
| 86803 | <1% | 833 | $90.75 | |
| 96381 | <1% | 17 | $88.80 | |
| 87340 | <1% | 1,020 | $82.81 | |
| 83020 | <1% | 289 | $79.90 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 320 | $66.08 |
| 86850 | <1% | 609 | $29.62 | |
| 99173 | <1% | 932 | $27.27 | |
| 86787 | <1% | 272 | $16.38 | |
| 86900 | <1% | 646 | $11.37 | |
| 86280 | <1% | 59 | $9.67 | |
| 86901 | <1% | 645 | $7.58 | |
| 99177 | 0% | 6,597 | $0.00 | |
| 91300 | 0% | 2,239 | $0.00 | |
| 81443 | 0% | 152 | $0.00 | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 0% | 243 | $0.00 |
| 90685 | 0% | 163 | $0.00 | |
| 91312 | 0% | 71 | $0.00 | |
| LU283 | 0% | 14 | $0.00 | |
| 90697 | 0% | 990 | $0.00 | |
| 91307 | 0% | 838 | $0.00 | |
| 86762 | 0% | 901 | $0.00 | |
| 90744 | 0% | 371 | $0.00 | |
| 90696 | 0% | 91 | $0.00 | |
| 90620 | 0% | 428 | $0.00 | |
| 91305 | 0% | 261 | $0.00 | |
| 90660 | 0% | 18 | $0.00 | |
| 90723 | 0% | 55 | $0.00 | |
| 91301 | 0% | 59 | $0.00 | |
| 90647 | 0% | 28 | $0.00 | |
| 90381 | 0% | 80 | $0.00 | |
| 91303 | 0% | 22 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 61 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, BRITTANY (BILLING SUPERVISOR)